BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9893258)

  • 1. Bone stem cells.
    Aubin JE
    J Cell Biochem Suppl; 1998; 30-31():73-82. PubMed ID: 9893258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the osteoblast lineage.
    Aubin JE
    Biochem Cell Biol; 1998; 76(6):899-910. PubMed ID: 10392704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone stem cells.
    Aubin JE
    J Cell Biochem; 1998; 72 Suppl 30-31(S30-31):73-82. PubMed ID: 29345825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling stem cell development by retrospective analysis of gene expression profiles in single progenitor-derived colonies.
    Madras N; Gibbs AL; Zhou Y; Zandstra PW; Aubin JE
    Stem Cells; 2002; 20(3):230-40. PubMed ID: 12004081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal bone cells for tissue engineering.
    Montjovent MO; Burri N; Mark S; Federici E; Scaletta C; Zambelli PY; Hohlfeld P; Leyvraz PF; Applegate LL; Pioletti DP
    Bone; 2004 Dec; 35(6):1323-33. PubMed ID: 15589213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recql4 haploinsufficiency in mice leads to defects in osteoblast progenitors: Implications for low bone mass phenotype.
    Yang J; Murthy S; Winata T; Werner S; Abe M; Prahalad AK; Hock JM
    Biochem Biophys Res Commun; 2006 May; 344(1):346-52. PubMed ID: 16600186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of craniosynostotic osteoprogenitors and bioactive scaffolds for bone engineering.
    Santos-Ruiz L; Mowatt DJ; Marguerie A; Tukiainen D; Kellomäki M; Törmälä P; Suokas E; Arstila H; Ashammakhi N; Ferretti P
    J Tissue Eng Regen Med; 2007; 1(3):199-210. PubMed ID: 18038412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stem cell derived osteoblasts degrade organic bone matrix in vitro by matrix metalloproteinases.
    Parikka V; Väänänen A; Risteli J; Salo T; Sorsa T; Väänänen HK; Lehenkari P
    Matrix Biol; 2005 Sep; 24(6):438-47. PubMed ID: 16098718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass conditioned medium in the absence of osteogenic supplements.
    Tsigkou O; Jones JR; Polak JM; Stevens MM
    Biomaterials; 2009 Jul; 30(21):3542-50. PubMed ID: 19339047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
    Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells.
    Nöth U; Osyczka AM; Tuli R; Hickok NJ; Danielson KG; Tuan RS
    J Orthop Res; 2002 Sep; 20(5):1060-9. PubMed ID: 12382974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females.
    Abdallah BM; Haack-Sørensen M; Fink T; Kassem M
    Bone; 2006 Jul; 39(1):181-8. PubMed ID: 16530029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism.
    Thommesen L; Stunes AK; Monjo M; Grøsvik K; Tamburstuen MV; Kjøbli E; Lyngstadaas SP; Reseland JE; Syversen U
    J Cell Biochem; 2006 Oct; 99(3):824-34. PubMed ID: 16721825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.
    Rodda SJ; McMahon AP
    Development; 2006 Aug; 133(16):3231-44. PubMed ID: 16854976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells.
    Tang Z; Sahu SN; Khadeer MA; Bai G; Franklin RB; Gupta A
    Bone; 2006 Feb; 38(2):181-98. PubMed ID: 16203195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone cell precursors and the pathophysiology of bone loss.
    Blair HC; Carrington JL
    Ann N Y Acad Sci; 2006 Apr; 1068():244-9. PubMed ID: 16831925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of dexamethasone-dependent osteoprogenitors in cell populations derived from adult human female bone.
    Pei W; Yoshimine Y; Heersche JN
    Calcif Tissue Int; 2003 Feb; 72(2):124-34. PubMed ID: 12415421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of reloading on bone volume, osteoblast number, and osteoprogenitor characteristics: studies in hind limb unloaded rats.
    Basso N; Jia Y; Bellows CG; Heersche JN
    Bone; 2005 Sep; 37(3):370-8. PubMed ID: 16005699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein-2 induces the differentiation of a mesenchymal progenitor cell line, ROB-C26, into mature osteoblasts and adipocytes.
    Kato S; Kawabata N; Suzuki N; Ohmura M; Takagi M
    Life Sci; 2009 Feb; 84(9-10):302-10. PubMed ID: 19146860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.